Zynex Inc (ZYXI)

ZYXIQ: BK PLAN effective 'AFTER' the market closed, enough time for scurrilous cretins to unload 274,571 shares at .055. Rigged?????????????????????????????????????????????????????????????????

Condolences to the poor sap(s) who bought those shares. They're out over $15,000. Thanks Judge for waiting til the market closed to cancel the shares, ya jerk.

LOL
https://www.justice.gov/usao-ri/pr/former-zynex-inc-executives-charged-health-care-and-securities-fraud-and-related

ZYXI changed to ZYXIQ: bankruptcy. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

zyxi.........................................................A/H

ZYXI........................................https://stockcharts.com/sc3/ui/?s=ZYXI&p=W&b=5&g=0&id=p86431144783

Good to see others run scans & trade

Most just buy tripps & believe PRs and hope & pray.

GLTA

That’s how ya sell early prick

1.96 halt

Mother tucker. What a beast

1.80 another squeeze 

ZYXI....................................https://stockcharts.com/sc3/ui/?s=ZYXI&p=W&b=5&g=0&id=p86431144783

1.55 Not bad better run then Nov 10 1.20

ZYXI 1.50 top

1.44 magnitude quake precise charting analysis

Then 1.53

Here we go to magnetic resonance 1.44

1.44 magnitude magnetic storm

ZYXI monster

ZYXI here we go

Here we go

ZYXI dollar runner

Out magnet lost it’s pulling power

ZYXI 96c magnetic field

ZYXI dolla runner

.69.. Zynex Reports Third Quarter 2025 Financial ResultsNovember 17 2025 - 5:15PM
PR Newswire (US)http://www.facebook.com/sharer.php?s=100&p[url]=https%3A%2F%2Finvestorshub.advfn.com%2Fstock-market%2FNASDAQ%2FZYXI%2Fstock-news%2F97254786%2Fzynex-reports-third-quarter-2025-financial-resultsENGLEWOOD, Colo., Nov. 17, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, and rehabilitation, today reported its financial and operational results for the third quarter ended September 30, 2025.Management Commentary and Recent Events"Since joining the Company in August, the new management team has worked tirelessly to address the business and compliance challenges at Zynex while creating a new future for all our company," said Steven Dyson, Chief Executive Officer of Zynex.  "We have been focused on a three-part strategy: renewing our commitment to compliance and integrity, addressing the company's current liquidity challenges, and improving revenue and cash flow performance.  While the Third Quarter of 2025 was more of a continuation of first-half performance, we have seen progress with our strategy and we remain committed to rebuild and return the company to growth in the future."Zynex has engaged Province, LLC, an internationally recognized financial advisory firm, to assist on evaluating a range of strategic alternatives, including potential capital raising opportunities and recapitalization and restructuring strategies. In addition, Paul Aronzon has joined our Board of Directors and has been appointed as Chair of a Special Committee of the Zynex Board of Directors to oversee the assessment of the above-referenced strategic alternatives.  This Committee will work closely with management, Province and counsel to assess and implement the strategic alternatives, as appropriate.In order to preserve cash as the Company is evaluating strategic alternatives, Zynex has elected to enter the contractual thirty (30) day grace period and  will not make a $1.5 million interest payment, due November 17, 2025, on the Company's $60 million of Convertible Notes maturing in May 2026.  The Company is in discussions with Convertible Note holders regarding potential restructuring opportunities with an ad hoc group of holders of the Convertible Notes, represented by Brown Rudnick LLP. "We are taking decisive steps to ensure Zynex is well-positioned going forward," said Steven Dyson. "The engagement of Province and the formation of the Special Committee reflect our commitment to exploring all avenues to create a new future for Zynex."The Company has not yet identified a strategic transaction and there can be no assurance any such transaction will result from the Special Committee's evaluation of strategic alternatives, or the timing, terms and conditions of any such transaction.Third Quarter 2025 Financial ResultsNet revenue was $13.4 million for the three months ended September 30, 2025, compared to $50.0 million in the prior year quarter. The declines in net revenue for the three months ended September 30, 2025 compared to the prior year period are primarily related to the Company's Tricare payment suspension, along with a $2.8 million reduction in revenue related to payments received from Tricare during the suspension period. Through the third quarter of 2025, changes to certain payers' claim submission and review practices have resulted in denials and payment delays, which has negatively impacted revenue. Additionally, workforce reductions in the first and second quarters of 2025 have negatively impacted device orders and corresponding supplies, new patients onboarding and order completion, contributing to the overall decline in net revenue during the three months ended September 30, 2025.Gross profit in the quarter ended September 30, 2025, was $8.1 million, or 60% of revenue, as compared to $39.8 million or 80% of revenue, in the third quarter of 2024. Gross profit was lower due to the decrease in revenue, decreased revenue related to the Tricare revenue adjustment which had no corresponding decrease to cost of revenue, and less volume in our production facility to absorb fixed costs.Sales and marketing expense for the three months ended September 30, 2025, decreased 54% to $9.5 million from $20.7 million for the same period in 2024, primarily due to decreased headcount in the sales force.General and administrative expenses for the three months ended September 30, 2025, were $11.8 million, versus $15.3 million in the prior year period.Net loss for the three months ended September 30, 2025, totaled ($42.9) million, or ($1.42) per basic and diluted share. In addition to our decline in revenue net loss was also negatively impacted by a non-cash asset impairment charge of $30.7 million during the quarter ended September 30, 2025, primarily related to goodwill, definite-lived intangible assets and certain fixed assets associated with Zynex Monitoring Solutions, Inc.For the quarter ended September 30, 2024, net income was $2.3 million, or $0.07 per basic and diluted share.Adjusted EBITDA loss for the three months ended September 30, 2025, was ($12.3) million, as compared to Adjusted EBITDA of $5.1 million in the quarter ended September 30, 2024.Cash flow from operations for the three and nine months ended September 30, 2025, was ($6.3) million and ($23.0) million, respectively. As of September 30, 2025, the Company had cash and cash equivalents of $13.3 million.Earnings Call DetailsDate: Tuesday, November 18, 2025
Time: 9:00 AM Eastern Time (7:00 AM Mountain Time)
U.S. & Canada dial-in number: 800-836-8184
International number: 646-357-8785
Webcast: Q3 2025 Webcast LinkNon-GAAP Financial Measures

Pumpathon 

ZYXI..............................................................a/h

Closed at 11.76 looking great

What just another GREAT Quarter And they keep reducing the amount of shares out there with there buy back program

One of the best things you could do The shorts cant short if there are no shares out there

Is that a good thing?

They are buying back another 10 million dollars worth that will make 50 million dollars in buybacks in 2 years

Same thing i said. Idk whats going on.

Wtf is going on with this company man seriously?

In 1 month, -16.57% in losses. Something is up. Is it the CEO Thomas Sandgaard leadership? Please someone make it make sense!

WTF

Its an obvious scenario Trading at less than 2X revenue

On a rumor? Ha Ha

What's your source?

I keep hearing there going private!!! Have you gotten any info on this?

My first purchase was apx 20 years ago too. Quite a ride...
Good luck!
Unbelievable it is as cheap as it is right now.

I think i have owned some for 20 years or longer(don't quote me on time) I have bought as low as 10 cents Fun to watch Enjoy the ride

We will, IMHO
Great company, great future.
Buy now and smile later

How can we have these prices We should be like a 40 dollar stock as we speak

To 10.78 a share

Is anyone hearing rumors that Zynex is going private?

news is out

Year end numbers come out after hours!! Good luck to everyone

Merry Christmas does anyone think we will get a rally towards the end of the year?

i Like the 13.85 but I believe we still go higher from here Anyone heard anything on the blood volume monitor?

It looks like we are going to break out from here (hello naked shorts) This might be fun